Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudi A Dierckx

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Hellenic Journal of Nuclear Medicine|April 21, 2005
Functional imaging: where is the future?Andreas Otte, Rudi A Dierckx
Nuclear Medicine Communications|June 9, 2005
Good clinical practice: a plea for nuclear medicineAndreas Otte, Rudi A Dierckx
Nuclear Medicine Communications|November 3, 2005
Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk?Andreas Otte, Rudi A Dierckx
Hellenic Journal of Nuclear Medicine|May 12, 2005
The future of nuclear medicineAndreas Otte, Rudi A Dierckx
Nuclear Medicine Review. Central & Eastern Europe|June 22, 2005
The hospital organization of the futureAndreas Otte, Rudi A Dierckx, Karina Otte
Nuclear Medicine Communications|June 9, 2005
Good clinical practice: historical background and key aspectsAndreas Otte, Herbert Maier-Lenz, Rudi A Dierckx
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2002
Clinical relevance of left ventricular volume assessment by gated myocardial SPET in patients with coronary artery diseaseOlivier De Winter, Johan De Sutter, Rudi A Dierckx
Nuclear Medicine Communications|August 13, 2005
Functional neuroimaging endpoints in drug developmentAndreas Otte, Kurt Audenaert, Kathelijne Peremans, et al.
Nuclear Medicine Communications|November 21, 2008
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next stepAndreas Otte, Christophe van de Wiele, Rudi A Dierckx
Nuclear Medicine Communications|June 9, 2005
The good laboratory practice and good clinical practice requirements for the production of radiopharmaceuticals in clinical researchFilip J De Vos, Mario De Decker, Rudi A Dierckx
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Hellenic Journal of Nuclear Medicine|April 21, 2005
Functional imaging: where is the future?Andreas Otte, Rudi A Dierckx
Nuclear Medicine Communications|June 9, 2005
Good clinical practice: a plea for nuclear medicineAndreas Otte, Rudi A Dierckx
Nuclear Medicine Communications|November 3, 2005
Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk?Andreas Otte, Rudi A Dierckx
Hellenic Journal of Nuclear Medicine|May 12, 2005
The future of nuclear medicineAndreas Otte, Rudi A Dierckx
Nuclear Medicine Review. Central & Eastern Europe|June 22, 2005
The hospital organization of the futureAndreas Otte, Rudi A Dierckx, Karina Otte
Nuclear Medicine Communications|June 9, 2005
Good clinical practice: historical background and key aspectsAndreas Otte, Herbert Maier-Lenz, Rudi A Dierckx
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2002
Clinical relevance of left ventricular volume assessment by gated myocardial SPET in patients with coronary artery diseaseOlivier De Winter, Johan De Sutter, Rudi A Dierckx
Nuclear Medicine Communications|August 13, 2005
Functional neuroimaging endpoints in drug developmentAndreas Otte, Kurt Audenaert, Kathelijne Peremans, et al.
Nuclear Medicine Communications|November 21, 2008
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next stepAndreas Otte, Christophe van de Wiele, Rudi A Dierckx
Nuclear Medicine Communications|June 9, 2005
The good laboratory practice and good clinical practice requirements for the production of radiopharmaceuticals in clinical researchFilip J De Vos, Mario De Decker, Rudi A Dierckx
Pageof 13